On September 5, 2023, the Company announced the appointment of Joshua DeTillio, age 47, as the Company’s Chief Operating Officer, effective on October 2, 2023 (the "Commencement Date").
Key facts
Extracted from this filing and checked against the source text.
Executive changeSEC 8-K Item 5.02confidence 1.0
Joshua DeTillio was appointed as Chief Operating Officer at Nutex Health Inc..
Action
appointed
Role
Chief Operating Officer
Exact text from the filing
On September 5, 2023, the Company announced the appointment of Joshua DeTillio, age 47, as the Company’s Chief Operating Officer, effective on October 2, 2023 (the "Commencement Date").
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.